High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study (Q40587278)
scientific article published on February 2002
Language:
(P31) (Q13442814)
(Q45182324)
(P50) (Q67501062)
(Q1684897)
(Q89328870)
(P304) 1363-1372
(P407) (Q1860)
(P433) 4 Suppl
(P478) 94
(P577) Friday, February 1, 2002
(P921) (Q1138590)
(P1104) 10
(P1433) (Q326041)
(P1476) "High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study" (language: en)
(P2093) Frank Griesinger
Joachim Riggert
Cornelia C Kaufmann
Bernhard Wörmann
Gerhard Brittinger
Wolfgang Becker
(P2860) (Q40435010)
(Q77788688)
(Q74238074)
(Q41844277)
(Q44080136)
(Q44656909)
(Q33857099)
(Q73218725)
(Q38532869)
(Q71734184)
(Q69124221)
other details
description scientific article published on February 2002

External Links